RecruitingNCT06893588

Registry on NeVa VS for CerebraL VAsospasm ManagemenT in Post SAH PatiEnts

Prospective, Open-Label, Multi-Center ProceDural Data CollectIon Case Registry on NeVa VS for CerebraL VAsospasm ManagemenT in Post SAH PatiEnts (The DILATE Registry)

Sponsor

Vesalio

Enrollment

200 participants

Start Date

Apr 14, 2025

Study Type

OBSERVATIONAL

Conditions

Cerebral Vasospasm Aneurysmal Subarachnoid Hemorrhage (aSAH)

Summary

A multi-center, observational registry study intended to assess the HDE-approved NeVa VS cerebral artery dilation device in patients with symptomatic cerebral vasospasm caused by aneurysmal subarachnoid hemorrhage (aSAH)

Eligibility

Min Age: 22 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a medical device called NEVA VS for people with aneurysmal subarachnoid hemorrhage (asah) and cerebral vasospasm. The study is currently recruiting participants at 16 locations. People eligible for this study include aged 22 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICENEVA VS

cerebral artery dilation device

Locations(16)

Providence St. Joseph Medical Center

Burbank, California, United States

John Muir Health

Walnut Creek, California, United States

Yale

New Haven, Connecticut, United States

Baptist Health South Florida

Miami, Florida, United States

Wellstar Health System

Marietta, Georgia, United States

Endeavor Health

Evanston, Illinois, United States

Univ Iowa

Iowa City, Iowa, United States

Univ Kentucky

Lexington, Kentucky, United States

MaineHealth

Portland, Maine, United States

Mayo Clinic- Rochester

Rochester, Minnesota, United States

Allegheny Health Network

Pittsburgh, Pennsylvania, United States

Geisinger

Wilkes-Barre, Pennsylvania, United States

Valley Baptist Medical Center- Harlingen

Harlingen, Texas, United States

University of Texas Health Science Center at Houston

Houston, Texas, United States

Uni. of Utah

Salt Lake City, Utah, United States

West Virginia University

Morgantown, West Virginia, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06893588

Related Trials

Nitric Oxide Consumption as a Predictor of Vasospasm in Subarachnoid Hemorrhage

NCT076149062 locations

Intranasal Sphenopalatine Ganglion Blockade for Headaches Following Aneurysmal Subarachnoid Hemorrhage

NCT071164081 location

DIND in Patients With aSAH : Real World Study

NCT071600881 location

Efficacy of Scalp Block in Managing Post Subarachnoid Hemorrhage Headache in Critically Ill Patients. A Single Centre Randomized Controlled Trial

NCT073075081 location

Incidence, Characteristics and Evolution of Cerebral Vasospasm With Clinical Impact in Moderate to Severe Traumatic Brain Injury Complicated by Subarachnoid Hemorrhage at Martinique University Hospital

NCT065603721 location